Old Web
English
Sign In
Acemap
>
authorDetail
>
Yoshiro Nagakute Aza-arata Ishiwata
Yoshiro Nagakute Aza-arata Ishiwata
Tokyo University of Science
MHC class I
Immunotherapy
Immune checkpoint
Blockade
CD8
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
2021
Cancer immunology research
Chang-Yu Chen
Satoshi Ueha
Yoshiro Nagakute Aza-arata Ishiwata
Shigeyuki Shichino
Shoji Yokochi
De Yang
Joost J. Oppenheim
Haru Ogiwara
Shungo Deshimaru
Yuzuka Kanno
Hiroyasu Aoki
Tatsuro Ogawa
Shiro Shibayama
Kouji Matsushima
Show All
Source
Cite
Save
Citations (1)
Combining an alarmin HMGN1 peptide with PD-L1 blockade facilitates stem-like CD8+ T cell expansion and results in robust antitumor effects
2020
bioRxiv
Chang-Yu Chen
Satoshi Ueha
Yoshiro Nagakute Aza-arata Ishiwata
Shigeyuki Shichino
Shoji Yokochi
De Yang
Joost J. Oppenheim
Haru Ogiwara
Shungo Deshimaru
Yuzuka Kanno
Tatsuro Ogawa
Shiro Shibayama
Kouji Matsushima
Show All
Source
Cite
Save
Citations (2)
1